Fresenius Medical Care AG & Co. (FMS) Given a $62.00 Price Target at SunTrust Banks

SunTrust Banks set a $62.00 price target on Fresenius Medical Care AG & Co. (NYSE:FMS) in a research note released on Thursday, December 21st. The brokerage currently has a buy rating on the stock.

Other research analysts have also issued reports about the stock. Royal Bank of Canada reissued a hold rating and set a $44.00 price target on shares of Fresenius Medical Care AG & Co. in a research report on Wednesday, September 13th. DZ Bank reissued a buy rating on shares of Fresenius Medical Care AG & Co. in a research report on Monday, November 13th. Morgan Stanley lowered shares of Fresenius Medical Care AG & Co. from an overweight rating to an equal weight rating in a research report on Monday, December 11th. Finally, Zacks Investment Research lowered shares of Fresenius Medical Care AG & Co. from a hold rating to a sell rating in a research report on Tuesday, October 3rd. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $55.67.

Fresenius Medical Care AG & Co. (NYSE:FMS) traded down $0.16 on Thursday, hitting $54.53. 179,612 shares of the company were exchanged, compared to its average volume of 153,153. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.22 and a quick ratio of 0.98. Fresenius Medical Care AG & Co. has a one year low of $40.02 and a one year high of $55.30. The company has a market capitalization of $33,120.00, a price-to-earnings ratio of 22.26, a P/E/G ratio of 2.27 and a beta of 0.45.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Harding Loevner LP increased its stake in shares of Fresenius Medical Care AG & Co. by 4,271.1% in the third quarter. Harding Loevner LP now owns 163,837,558 shares of the company’s stock worth $31,245,000 after purchasing an additional 160,089,385 shares in the last quarter. Cambiar Investors LLC grew its stake in Fresenius Medical Care AG & Co. by 3.8% during the third quarter. Cambiar Investors LLC now owns 2,695,714 shares of the company’s stock valued at $131,793,000 after acquiring an additional 99,234 shares in the last quarter. Royal Bank of Canada grew its stake in Fresenius Medical Care AG & Co. by 6.4% during the second quarter. Royal Bank of Canada now owns 501,694 shares of the company’s stock valued at $24,248,000 after acquiring an additional 30,119 shares in the last quarter. Parametric Portfolio Associates LLC grew its stake in Fresenius Medical Care AG & Co. by 8.9% during the third quarter. Parametric Portfolio Associates LLC now owns 431,183 shares of the company’s stock valued at $21,081,000 after acquiring an additional 35,064 shares in the last quarter. Finally, Jarislowsky Fraser Ltd grew its stake in Fresenius Medical Care AG & Co. by 1.2% during the third quarter. Jarislowsky Fraser Ltd now owns 294,871 shares of the company’s stock valued at $14,416,000 after acquiring an additional 3,556 shares in the last quarter. Hedge funds and other institutional investors own 3.03% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Fresenius Medical Care AG & Co. (FMS) Given a $62.00 Price Target at SunTrust Banks” was first posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.thelincolnianonline.com/2018/01/13/fresenius-medical-care-fms-given-a-62-00-price-target-by-suntrust-banks-analysts-updated-updated.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply